C-reactive protein as a prognostic tool in cardiovascular practices: should CRP testing be ordered along with lipid profiles?

著者: van der Bom, J.G., Cramer, M.J.M.
出版事項 2003

Risk Factors for Alloimmunisation after red blood Cell Transfusions (R-FACT): a case cohort study

著者: Zalpuri, Saurabh, Zwaginga, Jaap Jan, van der Bom, J G
出版事項 2012

Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia A— A Systematic Review and Meta-Analysis

著者: Abdi, A., Bordbar, M. R., Hassan, S., Rosendaal, F. R., van der Bom, J. G., Voorberg, J., Fijnvandraat, K., Gouw, S. C.
出版年 Front Immunol (2020)

Prospective validation of the EuroSCORE II risk model in a single Dutch cardiac surgery centre

著者: Hogervorst, E. K., Rosseel, P. M. J., van de Watering, L. M. G., Brand, A., Bentala, M., van der Meer, B. J. M, van der Bom, J. G.
出版年 Neth Heart J (2018)

Serum fatty acid chain length associates with prevalent symptomatic end-stage osteoarthritis, independent of BMI

著者: Meessen, J. M. T. A., Saberi-Hosnijeh, F., Bomer, N., den Hollander, W., van der Bom, J. G., van Hilten, J. A., van Spil, W. E., So-Osman, C., Uitterlinden, A. G., Kloppenburg, M., Nelissen, R. G. H. H., van Duijn, C. M., Slagboom, P. E., van Meurs, J. B. J., Meulenbelt, I.
出版年 Sci Rep (2020)

Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders

著者: Atiq, F., Saes, J.L., Punt, M.C., van Galen, K.P.M., Schutgens, R.E.G., Meijer, K., Cnossen, M.H., Laros-Van Gorkom, B.A.P., Peters, M., Nieuwenhuizen, L., Kruip, M.J.H.A., de Meris, J., van der Bom, J.G., van der Meer, F.J.M., Fijnvandraat, K., Kruis, I.C., van Heerde, W.L., Eikenboom, H.C.J., Leebeek, Frank W.G., Schols, S.E.M.
出版年 EClinicalMedicine (2021)